Follitropin alfa is indicated for:
Population group: women, only adults (18 - 65 years old)
Anovulation (including polycystic ovarian syndrome) in women who have been unresponsive to treatment with clomifene citrate.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: women, only adults (18 - 65 years old)
Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer and zygote intra-fallopian transfer.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: women, only adults (18 - 65 years old)
Follitropin alfa in association with a luteinising hormone (LH) preparation is recommended for the stimulation of follicular development in women with severe LH and FSH deficiency. In clinical trials these patients were defined by an endogenous serum LH level<1.2 IU/L.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: men, only adults (18 - 65 years old)
Follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotropic hypogonadism with concomitant human chorionic gonadotropin (hCG) therapy.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Follitropin alfa is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
